Industry News
FDA approves treatment for patients with rare bone marrow disorder
The U.S. Food and Drug Administration has approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis
The U.S. Food and Drug Administration has approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis
Paper published in Frontline Gastroenterology outlines new quality standards and benchmarking framework for inflammatory bowel disease
People who suffer a stroke caused by bleeding in the brain could be helped by four simple checks of their brain scans, research suggests
Scientists share their thoughts on essential day-to-day lab equipment
German public health authorities turn to modern blood tests amid the influx of refugees